Response to Baricitinib in the Treatment of Patients with Early and Late Onset Alopecia Areata in the Phase 2 Portion of BRAVE-AA1 Randomized Controlled Trial

September 2021 in “ Journal of The American Academy of Dermatology ”

Justin Ko, Janet Roberts, Maria Hordinsky, Susan C. Taylor, Arash Mostaghimi, Chiara Chiasserini, Yuxin Ding, Yunfei Chen, Wen‐Chi Wu, Yves Dutronc

baricitinib alopecia areata BRAVE-AA1 randomized controlled trial

TLDR Baricitinib was effective in treating both early and late onset alopecia areata.

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on jaad.org →

Discuss this study in the Community →

4 / 4 results

research Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss

1 citations , September 2022 in “Journal of The American Academy of Dermatology”

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

research Disorders of Hair

July 2013 in “DeckerMed Medicine”

The document's conclusion cannot be provided because the document is not readable or understandable.

research Hair Diseases: Alopecia Areata and Androgenetic Alopecia

January 2010

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

research Interventions for Alopecia Areata

2 citations , February 2009 in “Journal of Evidence-Based Medicine”

No treatment showed significant long-term hair growth benefits for alopecia areata.